Intra-Cellular Therapies, Inc.
Edit Page
Report
Scan day: 12 February 2014 UTC
11
Virus safety - good
Description: Developing novel drugs against targets inside nerve cells to treat CNS disorders. Includes therapeutic projects, target biochemistry, corporate data and contacts for headquarters in New York City.
Intra-Cellular Therapies, Inc. (ITI) is a biopharmaceutical company that is developing novel drugs for the treatment of diseases and disorders of the Central Nervous System (CNS). Building on the science generated from the Nobel Prize winning laboratory of Dr. Paul Greengard at The Rockefeller University, the Company develops compounds that have the potential to treat a wide range of diseases associated with the central nervous system. To aid in the development process, the Company incorporates its CNSProfile
Size: 514 chars
Contact Information
Email: —
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
| Page title: | Home |
| Keywords: | |
| Description: | |
| IP-address: | 70.47.94.100 |
WHOIS Info
| NS | Name Server: DNS010.D.REGISTER.COM Name Server: DNS019.C.REGISTER.COM Name Server: DNS020.B.REGISTER.COM Name Server: DNS160.A.REGISTER.COM |
| WHOIS | Status: clientTransferProhibited |
| Date | Creation Date: 25-mar-2002 Expiration Date: 25-mar-2017 |